Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Bassig BA, Inskip PD, Burdette L, Shapiro WR, Selker RG, Fine HA, Loeffler JS, Black PM, Dubrow R, Brenner AV.

J Neuroimmunol. 2011 Apr;233(1-2):185-91. doi: 10.1016/j.jneuroim.2010.11.005. Epub 2010 Dec 30.

2.

DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma.

Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Rothman N, Linet MS, Inskip PD.

Neuro Oncol. 2010 Jan;12(1):37-48. doi: 10.1093/neuonc/nop012. Epub 2009 Dec 10.

3.

Occupational exposure to magnetic fields and the risk of brain tumors.

Coble JB, Dosemeci M, Stewart PA, Blair A, Bowman J, Fine HA, Shapiro WR, Selker RG, Loeffler JS, Black PM, Linet MS, Inskip PD.

Neuro Oncol. 2009 Jun;11(3):242-9. doi: 10.1215/15228517-2009-002. Epub 2009 Feb 20.

4.

Oxidative response gene polymorphisms and risk of adult brain tumors.

Rajaraman P, Hutchinson A, Rothman N, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Linet MS, Inskip PD.

Neuro Oncol. 2008 Oct;10(5):709-15. doi: 10.1215/15228517-2008-037. Epub 2008 Aug 5.

5.

Genetic variation in insulin-like growth factors and brain tumor risk.

Lönn S, Rothman N, Shapiro WR, Fine HA, Selker RG, Black PM, Loeffler JS, Hutchinson AA, Inskip PD.

Neuro Oncol. 2008 Aug;10(4):553-9. doi: 10.1215/15228517-2008-026. Epub 2008 Jun 18.

6.

Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults.

Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Chanock SJ, Inskip PD.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1655-61.

7.

Lead, genetic susceptibility, and risk of adult brain tumors.

Rajaraman P, Stewart PA, Samet JM, Schwartz BS, Linet MS, Zahm SH, Rothman N, Yeager M, Fine HA, Black PM, Loeffler J, Shapiro WR, Selker RG, Inskip PD.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2514-20.

8.

Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults.

Bluhm EC, Zahm SH, Fine HA, Black PM, Loeffler JS, Shapiro WR, Selker RG, Inskip PD.

Am J Epidemiol. 2007 Jan 1;165(1):63-71. Epub 2006 Nov 1.

PMID:
17079691
9.

Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors.

De Roos AJ, Rothman N, Brown M, Bell DA, Pittman GS, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD.

Neuro Oncol. 2006 Apr;8(2):145-55. Epub 2006 Jan 27.

10.

Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults.

Rajaraman P, Schwartz BS, Rothman N, Yeager M, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Environ Health Perspect. 2005 Sep;113(9):1209-11.

11.

Self-reported electrical appliance use and risk of adult brain tumors.

Kleinerman RA, Linet MS, Hatch EE, Tarone RE, Black PM, Selker RG, Shapiro WR, Fine HA, Inskip PD.

Am J Epidemiol. 2005 Jan 15;161(2):136-46.

PMID:
15632263
12.

Reproductive and hormonal factors and risk of brain tumors in adult females.

Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Int J Cancer. 2005 May 1;114(5):797-805.

13.

Meningioma and schwannoma risk in adults in relation to family history of cancer.

Hill DA, Linet MS, Black PM, Fine HA, Selker RG, Shapiro WR, Inskip PD.

Neuro Oncol. 2004 Oct;6(4):274-80.

14.

Season of birth and risk of brain tumors in adults.

Brenner AV, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD.

Neurology. 2004 Jul 27;63(2):276-81.

PMID:
15277620
15.

Occupation and risk of meningioma and acoustic neuroma in the United States.

Rajaraman P, De Roos AJ, Stewart PA, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Am J Ind Med. 2004 May;45(5):395-407.

PMID:
15095422
16.

Cancer in first-degree relatives and risk of glioma in adults.

Hill DA, Inskip PD, Shapiro WR, Selker RG, Fine HA, Black PM, Linet MS.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1443-8.

17.

Occupation and the risk of adult glioma in the United States.

De Roos AJ, Stewart PA, Linet MS, Heineman EF, Dosemeci M, Wilcosky T, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD.

Cancer Causes Control. 2003 Mar;14(2):139-50.

PMID:
12749719
18.

Sociodemographic indicators and risk of brain tumours.

Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Fine HA, Black PM, Loeffler JS, Shapiro WR, Selker RG, Linet MS.

Int J Epidemiol. 2003 Apr;32(2):225-33.

PMID:
12714541
19.

Handedness and risk of brain tumors in adults.

Inskip PD, Tarone RE, Brenner AV, Fine HA, Black PM, Shapiro WR, Selker RG, Linet MS.

Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):223-5.

20.

Laterality of brain tumors.

Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Selker RG, Fine HA, Black PM, Loeffler JS, Shapiro WR, Linet MS.

Neuroepidemiology. 2003 Mar-Apr;22(2):130-8.

PMID:
12629279
21.

Polio vaccination and risk of brain tumors in adults: no apparent association.

Brenner AV, Linet MS, Selker RG, Shapiro WR, Black PM, Fine HA, Inskip PD.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):177-8. No abstract available.

22.

Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors.

De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Pittman GS, Bell DA.

Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):14-22.

23.

The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.

Selker RG, Shapiro WR, Burger P, Blackwood MS, Arena VC, Gilder JC, Malkin MG, Mealey JJ Jr, Neal JH, Olson J, Robertson JT, Barnett GH, Bloomfield S, Albright R, Hochberg FH, Hiesiger E, Green S; Brain Tumor Cooperative Group.

Neurosurgery. 2002 Aug;51(2):343-55; discussion 355-7.

PMID:
12182772
24.

History of allergies and autoimmune diseases and risk of brain tumors in adults.

Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD.

Int J Cancer. 2002 May 10;99(2):252-9.

25.

Cellular-telephone use and brain tumors.

Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine HA, Black PM, Loeffler JS, Linet MS.

N Engl J Med. 2001 Jan 11;344(2):79-86.

26.

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.

Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Vick NA, Rampling R, Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VA.

Br J Cancer. 2000 Sep;83(5):588-93.

28.

The erythrocyte sedimentation rate: an interface between science and the law.

Selker RG, Wilder BL.

Surg Neurol. 1995 Mar;43(3):290-3; discussion 293-5.

PMID:
7792696
29.

Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A.

Hiesiger EM, Green SB, Shapiro WR, Burger PC, Selker RG, Mahaley MS Jr, Ransohoff J 2nd, VanGilder JC, Mealey J Jr, Robertson JT, et al.

J Neurooncol. 1995;25(2):143-54.

PMID:
8543970
30.
31.

A comparison of the relative chemosensitivity of human gliomas to tamoxifen and n-desmethyltamoxifen in vitro.

Vertosick FT Jr, Selker RG, Randall MS, Kristofik MP, Rehn T.

J Neurooncol. 1994;19(2):97-103.

PMID:
7964994
32.
33.

The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: preliminary results in a series of "failed" patients.

Vertosick FT Jr, Selker RG, Pollack IF, Arena V.

Neurosurgery. 1992 Jun;30(6):897-902; discussion 902-3.

PMID:
1377370
34.

A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.

Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JC, Robertson JT, Mealey J Jr, Ransohff J, Mahaley MS Jr.

J Neurosurg. 1992 May;76(5):772-81.

PMID:
1564540
35.

Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways.

Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr.

J Neurosurg. 1991 Aug;75(2):284-93.

PMID:
1649272
36.

Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography.

Vertosick FT Jr, Selker RG, Arena VC.

Neurosurgery. 1991 Apr;28(4):496-501. Review.

PMID:
1851971
37.

Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.

Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr.

Cancer Res. 1990 Nov 15;50(22):7134-8.

38.

Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series.

Vertosick FT Jr, Selker RG.

Neurosurgery. 1990 Oct;27(4):516-21; discussion 521-2.

PMID:
2172859
39.

The risk and efficacy of anticoagulant therapy in the treatment of thromboembolic complications in patients with primary malignant brain tumors.

Altschuler E, Moosa H, Selker RG, Vertosick FT Jr.

Neurosurgery. 1990 Jul;27(1):74-6; discussion 77.

PMID:
2377284
40.

Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium.

Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT.

J Neurosurg. 1990 Jul;73(1):106-12.

PMID:
2352010
41.

Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways.

Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr.

J Neurosurg. 1990 Jul;73(1):98-105.

PMID:
2161913
42.

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

Shapiro WR, Green SB, Burger PC, Mahaley MS Jr, Selker RG, VanGilder JC, Robertson JT, Ransohoff J, Mealey J Jr, Strike TA, et al.

J Neurosurg. 1989 Jul;71(1):1-9.

PMID:
2661738
43.

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.

Deutsch M, Green SB, Strike TA, Burger PC, Robertson JT, Selker RG, Shapiro WR, Mealey J Jr, Ransohoff J 2nd, Paoletti P, et al.

Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1389-96.

PMID:
2542193
44.
45.

Glioma recurrence after interstitial irradiation.

Selker RG.

Neurosurgery. 1988 Jul;23(1):128. No abstract available.

PMID:
3173654
46.

Brain-tumor cell kinetics correlated with survival.

Bookwalter JW 3rd, Selker RG, Schiffer L, Randall M, Iannuzzi D, Kristofik M.

J Neurosurg. 1986 Dec;65(6):795-8.

PMID:
3772478
47.
48.

Immunobiology of primary intracranial tumors. Part 10: Therapeutic efficacy of interferon in the treatment of recurrent gliomas.

Mahaley MS Jr, Urso MB, Whaley RA, Blue M, Williams TE, Guaspari A, Selker RG.

J Neurosurg. 1985 Nov;63(5):719-25.

PMID:
2414420
49.

Effects of induced total-body hyperthermia on phosphorus metabolism in humans.

Guntupalli KK, Sladen A, Selker RG, Weinstock E, Wilks DH, Passmore J, Guntupalli JS.

Am J Med. 1984 Aug;77(2):250-4.

PMID:
6465174
50.

Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.

Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, Mealey J Jr, Odom GL, Paoletti P, Ransohoff J 2nd, Robertson JT, Selker RG, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA.

Cancer Treat Rep. 1983 Feb;67(2):121-32.

PMID:
6337710

Supplemental Content

Loading ...
Support Center